Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial was looking at a drug called ASA404 in combination with paclitaxel and carboplatin for non small cell lung cancer (NSCLC) that was stage 3B or 4.
Doctors often use chemotherapy to treat NSCLC that is or has spread to another part of the body. Paclitaxel and carboplatin are chemotherapy drugs that may be used.
Cancer cells need a blood supply to help them grow and survive. Growing cancer cells can stimulate the growth of new blood vessels. This is called angiogenesis.
Recruitment start: 8 April 2008
Recruitment end: 20 May 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Eisen
Novartis
Last reviewed: 16 Oct 2012
CRUK internal database number: 2749